Literature DB >> 8586082

Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.

M Rehling1, B V Nielsen, E B Pedersen, L E Nielsen, H E Hansen, T Bacher.   

Abstract

. This investigation was undertaken in order to determine whether the clearance of technetium-99m mercaptoacetyltriglycine (99mTc-MAG3) is more closely correlated to the clearance of iodine-125 orthoiodohippurate (125I-OIH) than to the clearance of chromium-51 ethylene diamine tetra-acetate (51Cr-EDTA) and whether there is a clinically significant extrarenal clearance of 99mTc-MAG3 . Fifty-one patients with a glomerular filtration rate (GFR) of 4-132ml/min were studied. After a simultaneous single injection of the three tracers, plasma clearance was measured from blood samples 0-5h post injection (p.i.) (0-24h in patients with GFR<15ml/min). Renal plasma clearance was measured 0-5h p.i. The ratio between the renal plasma clearance of 99mTc-MAG3 and 125I-OIH was 0.57. The ratio between the renal plasma clearance of 99mTc-MAG3 and 51Cr-EDTA was 2.57. The coefficient of variation (CV) of the 99mTc-MAG3/125I-OIH ratio was significantly smaller than the CV of the 99mTc-MAG3/51Cr-EDTA ratio (13.4% versus 31.2%). The corresponding plasma clearance ratios were 0.59 (CV=14.8%) and 2.48 (CV=27.0%). Plasma clearance overestimated renal plasma clearance by 7.0ml/min (5.4%) for 99mTc-MAG3 and by 4.1ml/min (8.4%) for 51Cr-EDTA. The difference in plasma and renal plasma clearance of 125I-OIH of 5.5ml/min did not reach statistical significance. Red blood cell binding of 99mTc-MAG3, 125I-OIH and 51Cr-EDTA was 2.0%, 14.6% and 0.2%, respectively. Protein binding of 99mTc-MAG3, 125I-OIH and 51Cr-EDTA was 86.3%, 61.1% and 5.9%, respectively. The volume of distribution of 99mTc-MAG3, 125I-OIH and 51Cr-EDTA was 16.3%, 27.0% and 19.4% of body weight. In conclusion, the clearances of 99mTc-MAG3 and 125I-OIH are more closely correlated than is the clearance of 99mTc-MAG3 with GFR. Extrarenal clearance of 99mTc-MAG3 is relatively smaller than extrarenal clearance of 51Cr-EDTA. Thus, plasma clearance of 99mTc-MAG3 can be used as a measure of renal tubular function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586082     DOI: 10.1007/bf01791145

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Enhanced fractional sodium reabsorption in the ischaemic kidney revisited with lithium as a probe.

Authors:  N E Bruun; M Rehling; P Skøtt; J Giese
Journal:  Scand J Clin Lab Invest       Date:  1990-09       Impact factor: 1.713

2.  Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.

Authors:  R A Jafri; K E Britton; C C Nimmon; K Solanki; A Al-Nahhas; J Bomanji; J Fettich; L A Hawkins
Journal:  J Nucl Med       Date:  1988-02       Impact factor: 10.057

3.  99mTc-MAG3: dynamic studies in patients with renal disease.

Authors:  G H Schaap; T H Alferink; R B de Jong; P L Oe; J C Roos; A J Donker
Journal:  Eur J Nucl Med       Date:  1988

4.  Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man.

Authors:  M Rehling; M L Møller; B Thamdrup; J O Lund; J Trap-Jensen
Journal:  Clin Sci (Lond)       Date:  1984-05       Impact factor: 6.124

5.  Comparison between total and renal plasma clearance of [51Cr] EDTA.

Authors:  J B Mortensen; P Rödbro
Journal:  Scand J Clin Lab Invest       Date:  1976-05       Impact factor: 1.713

Review 6.  Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.

Authors:  D Eshima; A Taylor
Journal:  Semin Nucl Med       Date:  1992-04       Impact factor: 4.446

7.  Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.

Authors:  A Taylor; J A Ziffer; A Steves; D Eshima; V B Delaney; J D Welchel
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

8.  Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.

Authors:  A Taylor; D Eshima; P E Christian; W Milton
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

9.  Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.

Authors:  J A Prenen; J M de Klerk; A D van het Schip; P P van Rijk
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

10.  Comparative study of the kinetics of the renal tracers 99Tcm-MAG3 and 131I-hippuran.

Authors:  J Pavía; D Ros; C Piera; A Pavía; P Bassa; E Giralt; J Setoain
Journal:  Nucl Med Commun       Date:  1991-06       Impact factor: 1.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.